Apellis Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Apellis Pharmaceuticals's balance sheet done over the years? Its assets were worth $788,730,000 last year, which is more than in the previous period. 75% of Apellis Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $594,209,000, which means an increase by 1% compared compared to last year.
Debt to Assets
| 2014 | 14306238 | 1.08M | 7.56% |
|---|---|---|---|
| 2015 | 38177109 | 3.20M | 8.38% |
| 2016 | 27433258 | 3.63M | 13.26% |
| 2017 | 182131456 | 33.18M | 18.22% |
| 2018 | 203533559 | 42.56M | 20.91% |
| 2019 | 389244980 | 355.01M | 91.21% |
| 2020 | 960569000 | 756.01M | 78.7% |
| 2021 | 881765000 | 683.10M | 77.47% |
| 2022 | 760217000 | 590.34M | 77.65% |
| 2023 | 788730000 | 594.20M | 75.34% |
APLS Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 351.18M | 551.80M | 640.19M | 565.77M | 351.98M | 176.26M | 175.64M | 24.86M | 36.00M | 13.62M |
Short term investments | 1.11M | 6.50M | 60.35M | 311.86M | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 206.44M | 7.72M | 10.10M | 25M | 0 | 0 | 0 | 0 | 0 | 465.85K |
Inventory | 146.36M | 85.71M | 16.28M | 1 | 0 | 0 | 0 | 0 | 0 | 137.35K |
Other current assets | 61.22M | 36.65M | 70.67M | 26.87M | 1.30M | 1.83M | 6.37M | 2.50M | 2.04M | 158.49K |
Total current assets | 766.33M | 719.52M | 824.04M | 917.19M | 373.09M | 202.43M | 182.01M | 27.36M | 38.04M | 14.24M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 21.09M | 24.89M | 26.07M | 24.52M | 15.76M | 0 | 0 | 0 | 0 | 21.67K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 1.30M | 15.79M | 31.64M | 18.85M | 385.08K | 1.09M | 116.15K | 64.52K | 133.27K | 37.22K |
Total non-current assets | 22.39M | 40.69M | 57.71M | 43.37M | 16.15M | 1.09M | 116.15K | 64.52K | 133.27K | 58.89K |
Total assets | 788.73M | 760.21M | 881.76M | 960.56M | 389.24M | 203.53M | 182.13M | 27.43M | 38.17M | 14.30M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 103.23M | 111.93M | 0 | 0 | 0 | 0 | 0 | 0 |
Short term debt | 6.44M | 5.62M | 4.11M | 3.68M | 2.60M | 1.66M | 0 | 0 | 0 | 0 |
Total current liabilities | 247.59M | 167.61M | 131.84M | 128.32M | 65.75M | 17.02M | 6.55M | 3.63M | 3.20M | 1.08M |
| Non-current liabilities: | ||||||||||
Long term debt | 104.48M | 107.08M | 206.10M | 374.04M | 154.42M | 25.37M | 26.39M | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 242.12M | 315.64M | 345.15M | 253.63M | 134.83M | 158.78K | 244.29K | 0 | 0 | 0 |
Total non-current liabilities | 346.61M | 422.73M | 551.25M | 627.68M | 289.26M | 25.53M | 26.63M | 0 | 0 | 0 |
Total liabilities | 594.20M | 590.34M | 683.10M | 756.01M | 355.01M | 42.56M | 33.18M | 3.63M | 3.20M | 1.08M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |